GMO U.S. Value ETF (NYSEARCA:GMOV – Get Free Report) was the recipient of a significant increase in short interest in the month of August. As of August 31st, there was short interest totaling 3,614 shares, an increase of 610.0% from the August 15th total of 509 shares. Based on an average daily volume of 7,807 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.1% of the shares of the company are short sold.
GMO U.S. Value ETF Stock Performance
Shares of GMOV opened at $32.83 on Friday. The stock has a market capitalization of $105.06 million, a P/E ratio of 12.08 and a beta of 0.63. The company’s fifty day moving average is $31.92 and its two-hundred day moving average is $30.20. GMO U.S. Value ETF has a 1 year low of $25.66 and a 1 year high of $33.34.
GMO U.S. Value ETF Cuts Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, July 1st. Stockholders of record on Tuesday, June 30th were issued a $0.1283 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $0.51 annualized dividend and a dividend yield of 1.6%.
Institutional Inflows and Outflows
About GMO U.S. Value ETF
The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.
Featured Stories
- Five stocks we like better than GMO U.S. Value ETF
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
